OPKO Health Receives Important U.S. Patent Allowance

Apr 25, 2012

OPKO Health Announces the Start of Phase 3 Clinical Trials of Rolapitant for the Prevention of CINV

Apr 12, 2012

OPKO Health Acquires Chilean Pharmaceutical Company

Apr 4, 2012

OPKO Health Announces License Agreement for OPKO’s Alzheimer’s Diagnostic Technology

Apr 3, 2012

OPKO Health Expands Collaboration with Arctic Partners

Mar 19, 2012

OPKO Health and The Scripps Research Institute Announce Global License Agreement for a Novel Compound That Blocks Brain Cell Destruction in Parkinson’s Disease

Mar 9, 2012

OPKO Invests in BioZone Pharmaceuticals, Inc.

Feb 27, 2012

OPKO Health to Present at the Citi 2012 Global Health Care Conference

Feb 23, 2012

OPKO Health, Inc. Invests in ChromaDex® Corp.

Feb 15, 2012

OPKO Health to Acquire Chilean Pharmaceutical Company

Jan 23, 2012